Fig. 3: FDG-PET/CT images at baseline and after 16-week treatment with OHAs.
From: Clinical and biochemical factors associated with amygdalar metabolic activity
FDG-PET/CT images of high-responder and low-responder case. After 16-week add-on OHA therapy, there were some patients, whose amygdala metabolic activity was drastically decreased in response to the additional treatment of OHAs.
